1Meigs JB. Epidemiology of the metabolic syndrome, 2002. Am J Manag Care, 2002, 8(11 suppl):S283-92; quiz S293-6.
2Mogul HR, Weinstein BI, Mogul DB, et al. Syndrome W: a new model of hyperinsulinemia, hypertension and midlife weight gain in healthy women with normal glucose tolerance. Heart Dis,2002, 4:78-85.
3Bosello O, Zamboni M. Visceral obesity and metabolic syndrome.Obes Rev, 2000, 1:47-56.
4Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res, 2003,11:1480-1487.
5vonEyben FE, Mouritsen E, Holm J, et al. Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord, 2003, 27: 941-949.
6Han TS, Williams K, Sattar N, et al. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res, 2002, 10:923-931.
7Vanhala MJ, Vanhala PT, Keinanen-Kiukaanniemi SM, et al.Relative weight gain and obesity as a child predict metabolic syndrome as an adult. Int J Obes Relat Metab Disord, 1999, 23:656-659.
8Steinberger J. Diagnosis of the metabolic syndrome in children.Curr Opin Lipidol, 2003, 14:555-559.
9Anderson PJ, Critchley JA, Chan JC, et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord, 2001, 25:1782-1788.
10Maison P, Byrne CD, Hales CN, et al. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care, 2001,24:1758-1763.
5Nash DT.Relationship of C-reactive protein,metabolic syndrome and diabetes mellitus:potential role of statins.J Natl Med Assoc,2005,97(12):1600-1607.
6Alberti KG,Zimmet P,Shaw J.Metabolic syndrome-a new world-wide definition.A Consensus Statement from the International Diabetes Federation.Diabet Med,2006,23:469-480.
7Fogari R,Preti P,Zoppi A,et al.Effect of andodipine,fosinopril combinafion on microalbuminuria in hypertensive type 2 diabetes patiets[J].Am J Hypertens,2002,15(12):1042-1047.
8Girt AA,Prisant LM.LosartAN:first of new class of angiotensin antagonist for the management of hypertension[J].J Clin Pharmacol,1996,36(3):265-270.
9Nicklas BJ,Penninx BW,CesariM,et al.Association of vis-ceral adipose tissue with incident myocardial infarction in older men and women:the Health,Aging and Body Compo-sition Study[J].Am J Epidemiol,2004,160(8):741-749.
10Zheng T,Hasebe N. Nonlinear Dynamic Behaviors of a Complex Rotor-Bearing System [J]. ASME Journal of Applied Mechanics 67,2000: 485 - 495.
